GB9502297D0 - Novel compound - Google Patents

Novel compound

Info

Publication number
GB9502297D0
GB9502297D0 GBGB9502297.6A GB9502297A GB9502297D0 GB 9502297 D0 GB9502297 D0 GB 9502297D0 GB 9502297 A GB9502297 A GB 9502297A GB 9502297 D0 GB9502297 D0 GB 9502297D0
Authority
GB
United Kingdom
Prior art keywords
novel compound
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9502297.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9502297.6A priority Critical patent/GB9502297D0/en
Publication of GB9502297D0 publication Critical patent/GB9502297D0/en
Priority to GB9601917A priority patent/GB2297550B/en
Priority to ARP960101230A priority patent/AR001982A1/en
Priority to SK143-96A priority patent/SK283608B6/en
Priority to MYPI96000383A priority patent/MY132529A/en
Priority to EP96903970A priority patent/EP0808314B1/en
Priority to DE1996631298 priority patent/DE69631298T2/en
Priority to DE29623383U priority patent/DE29623383U1/en
Priority to MC2329A priority patent/MC2411A1/en
Priority to LVP-96-31A priority patent/LV11618B/en
Priority to RO96-00183A priority patent/RO112426B1/en
Priority to IE960104A priority patent/IE80500B1/en
Priority to MX9600484A priority patent/MX9600484A/en
Priority to EP01115079A priority patent/EP1136490B1/en
Priority to CZ0032096A priority patent/CZ297171B6/en
Priority to DE19603797A priority patent/DE19603797C2/en
Priority to EP03078024A priority patent/EP1378508A1/en
Priority to FR9601297A priority patent/FR2730232B1/en
Priority to AU43328/96A priority patent/AU701518C/en
Priority to AU47864/96A priority patent/AU4786496A/en
Priority to PCT/EP1996/000447 priority patent/WO1996024595A1/en
Priority to DE69621777T priority patent/DE69621777T2/en
Priority to BR9600534A priority patent/BR9600534A/en
Priority to SG1996000861A priority patent/SG43787A1/en
Priority to KR1019960002620A priority patent/KR100289885B1/en
Priority to DZ960030A priority patent/DZ1989A1/en
Priority to ES09600262A priority patent/ES2114471B1/en
Priority to PL96312646A priority patent/PL189247B1/en
Priority to DK011996A priority patent/DK11996A/en
Priority to JP8018679A priority patent/JP2915338B2/en
Priority to APAP/P/1996/000780A priority patent/AP9600780A0/en
Priority to UA96020442A priority patent/UA49796C2/en
Priority to CN96103526A priority patent/CN1090187C/en
Priority to BE9600101A priority patent/BE1009112A3/en
Priority to BG100333A priority patent/BG62967B1/en
Priority to IT96MI000203A priority patent/IT1289532B1/en
Priority to AT0021096A priority patent/AT407528B/en
Priority to CA002211521A priority patent/CA2211521A1/en
Priority to LU88711A priority patent/LU88711A1/en
Priority to ZA96875A priority patent/ZA96875B/en
Priority to CA002210023A priority patent/CA2210023C/en
Priority to GR960100038A priority patent/GR1002466B/en
Priority to SI9600378A priority patent/SI21923B/en
Priority to FI960519A priority patent/FI111544B/en
Priority to SE9600406A priority patent/SE521084C2/en
Priority to IL11703596A priority patent/IL117035A/en
Priority to TW085101374A priority patent/TW503238B/en
Priority to SI9600036A priority patent/SI9600036B/en
Priority to NL1002248A priority patent/NL1002248C2/en
Priority to CA002210022A priority patent/CA2210022C/en
Priority to ES9900042A priority patent/ES2149726B1/en
Priority to CNB2004100855519A priority patent/CN1289496C/en
Priority to LT96-007A priority patent/LT4100B/en
Priority to RU96102180A priority patent/RU2125052C1/en
Priority to CA002211522A priority patent/CA2211522C/en
Priority to CA002168829A priority patent/CA2168829C/en
Priority to NZ280943A priority patent/NZ280943A/en
Priority to NO960472A priority patent/NO301009B1/en
Priority to MA24157A priority patent/MA23802A1/en
Priority to HU9600255A priority patent/HUP9600255A1/en
Priority to OA60773A priority patent/OA10261A/en
Priority to CH00304/96A priority patent/CH688353A5/en
Priority to PT101827A priority patent/PT101827B/en
Priority to CH01510/97A priority patent/CH689229A5/en
Priority to CH02051/98A priority patent/CH689804A5/en
Priority to TR96/00096A priority patent/TR199600096A2/en
Priority to US08/608,782 priority patent/US5856493A/en
Priority to US08/733,874 priority patent/US5872132A/en
Priority to NO19970939A priority patent/NO311519B1/en
Priority to HK59397A priority patent/HK59397A/en
Priority to US08/922,060 priority patent/US5900423A/en
Priority to US08/922,067 priority patent/US6133289A/en
Priority to US08/922,062 priority patent/US6080759A/en
Priority to CY201598A priority patent/CY2015A/en
Priority to JP10342812A priority patent/JPH11228571A/en
Priority to CN001268872A priority patent/CN1216055C/en
Priority to DKPA200100223 priority patent/DK200100223A/da
Priority to DK200100774A priority patent/DK200100774A/en
Priority to NO20015070A priority patent/NO20015070D0/en
Priority to US10/217,258 priority patent/US20030004188A1/en
Priority to ARP020103931A priority patent/AR036856A2/en
Priority to FI20030162A priority patent/FI20030162A/en
Priority to FI20030370A priority patent/FI20030370A/en
Priority to US10/786,192 priority patent/US20040167227A1/en
Pending legal-status Critical Current

Links

GBGB9502297.6A 1995-02-06 1995-02-06 Novel compound Pending GB9502297D0 (en)

Priority Applications (84)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GB9601917A GB2297550B (en) 1995-02-06 1996-01-31 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
ARP960101230A AR001982A1 (en) 1995-02-06 1996-02-01 PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
SK143-96A SK283608B6 (en) 1995-02-06 1996-02-01 New forms of parotexin hydrochloride
MYPI96000383A MY132529A (en) 1995-02-06 1996-02-02 Paroxetine hydrochloride anhydrate
EP96903970A EP0808314B1 (en) 1995-02-06 1996-02-02 Forms of paroxetin hydrochloride
DE1996631298 DE69631298T2 (en) 1995-02-06 1996-02-02 paroxetine hydrochloride
DE29623383U DE29623383U1 (en) 1995-02-06 1996-02-02 New forms of paroxetine hydrochloride
MC2329A MC2411A1 (en) 1995-02-06 1996-02-02 New compounds
LVP-96-31A LV11618B (en) 1995-02-06 1996-02-02 Novel compounds
RO96-00183A RO112426B1 (en) 1995-02-06 1996-02-02 Anhydrous and solvated paraxetine chlorine hydrate, preparation process therefor and treatment and/or prevention method of some illness disturbing
IE960104A IE80500B1 (en) 1995-02-06 1996-02-02 Novel compounds
MX9600484A MX9600484A (en) 1995-02-06 1996-02-02 Novel compound.
EP01115079A EP1136490B1 (en) 1995-02-06 1996-02-02 Process for preparation of paroxetin hydrochloride anhydrate
CZ0032096A CZ297171B6 (en) 1995-02-06 1996-02-02 Paroxetine-hydrochloride anhydrate, process for its preparation, and pharmaceutical composition in which the anhydrate is comprised and use thereof
DE19603797A DE19603797C2 (en) 1995-02-06 1996-02-02 New forms of paroxetine hydrochloride
EP03078024A EP1378508A1 (en) 1995-02-06 1996-02-02 Various forms of paroxetine hydrochloride anhydrate
FR9601297A FR2730232B1 (en) 1995-02-06 1996-02-02 PAROXETINE HYDROCHLORIDE ANHYDRATE SUBSTANTIALLY FREE OF PROPANE-2-OL LIE, ITS THERAPEUTIC APPLICATION
AU43328/96A AU701518C (en) 1995-02-06 1996-02-02 A novel process for the production of paroxetine hydrochloride anhydrate, and certain novel polymorphs of paroxetine hydrochloride anhydrate
AU47864/96A AU4786496A (en) 1995-02-06 1996-02-02 New forms of paroxetin hydrochloride
PCT/EP1996/000447 WO1996024595A1 (en) 1995-02-06 1996-02-02 New forms of paroxetin hydrochloride
DE69621777T DE69621777T2 (en) 1995-02-06 1996-02-02 FORMS OF PAROXETINE HYDROCHLORIDE
BR9600534A BR9600534A (en) 1995-02-06 1996-02-02 New compounds
SG1996000861A SG43787A1 (en) 1995-02-06 1996-02-03 Novel paroxetine hydrochloride anhydrate
KR1019960002620A KR100289885B1 (en) 1995-02-06 1996-02-03 Parozetine hydrochloride anhydride, preparation method thereof and pharmaceutical composition containing same
DZ960030A DZ1989A1 (en) 1995-02-06 1996-02-04 New compounds.
ES09600262A ES2114471B1 (en) 1995-02-06 1996-02-05 NEW PAROXETINE COMPOUNDS AND PROCEDURE FOR THE PREPARATION.
PL96312646A PL189247B1 (en) 1995-02-06 1996-02-05 Novel chemical compounds
DK011996A DK11996A (en) 1995-02-06 1996-02-05 New compound, method of preparation thereof and use thereof for the manufacture of a medicament
JP8018679A JP2915338B2 (en) 1995-02-06 1996-02-05 New compound
APAP/P/1996/000780A AP9600780A0 (en) 1995-02-06 1996-02-05 Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
UA96020442A UA49796C2 (en) 1995-02-06 1996-02-05 paroxetine hydrochloride anhydrate, method for preparing the above, paroxetine hydrochloride, method of preparing the above, method of treating and/or diseases preventing and pharmaceutical composition
CN96103526A CN1090187C (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol
BE9600101A BE1009112A3 (en) 1995-02-06 1996-02-05 New compounds.
BG100333A BG62967B1 (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate
IT96MI000203A IT1289532B1 (en) 1995-02-06 1996-02-05 COMPOUNDS, OF PAROXETINE HYDROCHLORIDE AND PROCEDURES FOR THEIR PREPARATION
AT0021096A AT407528B (en) 1995-02-06 1996-02-05 NEW FORMS OF PAROXETINE HYDROCHLORIDE ANHYDRATE
CA002211521A CA2211521A1 (en) 1995-02-06 1996-02-05 Novel paroxetine hydrochlorine anhydrate forms
LU88711A LU88711A1 (en) 1995-02-06 1996-02-05 New compounds
ZA96875A ZA96875B (en) 1995-02-06 1996-02-05 Novel compounds
CA002210023A CA2210023C (en) 1995-02-06 1996-02-05 Process for the preparation of paroxetine hydrochloride anhydrate form a.
GR960100038A GR1002466B (en) 1995-02-06 1996-02-05 Novel compounds.
SI9600378A SI21923B (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate free of bound organic solvent
FI960519A FI111544B (en) 1995-02-06 1996-02-05 A process for the preparation of paroxetine hydrochloride anhydrate substantially free of bound organic solvent
SE9600406A SE521084C2 (en) 1995-02-06 1996-02-05 Process for Preparation of Paroxetine Hydrochloride Anhydrate from a Paroxetine Hydrochloride Solvate
IL11703596A IL117035A (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it
TW085101374A TW503238B (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate and its preparation
SI9600036A SI9600036B (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate free of bound organic solvent
NL1002248A NL1002248C2 (en) 1995-02-06 1996-02-05 New connections.
CA002210022A CA2210022C (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride solvates
ES9900042A ES2149726B1 (en) 1995-02-06 1996-02-05 NEW PAROXETINE COMPOUNDS.
CNB2004100855519A CN1289496C (en) 1995-02-06 1996-02-05 Process for producing novel form of paroxetine hydrochloride anhydrate
LT96-007A LT4100B (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate and process for preparing thereof
RU96102180A RU2125052C1 (en) 1995-02-06 1996-02-05 Paroxetin hydrochloride anhydrate, paroxetin hydrochloride solvates and methods of their preparing
CA002211522A CA2211522C (en) 1995-02-06 1996-02-05 Novel compounds
CA002168829A CA2168829C (en) 1995-02-06 1996-02-05 Paroxetine hydrochloride anhydrate forms a,b,c and d
NZ280943A NZ280943A (en) 1995-02-06 1996-02-05 Paroxetine trans-(-)-3-[(1,3-benzodioxol-5-yl)methoxy]-4-(4-fluorophenyl) piperidine). hcl free of bound solvent (particularly propan-2-ol) and various forms thereof
NO960472A NO301009B1 (en) 1995-02-06 1996-02-05 Paroksetinhydrokloridanhydrat
MA24157A MA23802A1 (en) 1995-02-06 1996-02-05 PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
HU9600255A HUP9600255A1 (en) 1995-02-06 1996-02-05 Various forms of paroxetin hydrochloride and process for their preparation
OA60773A OA10261A (en) 1995-02-06 1996-02-06 New paroxetine derivatives
CH00304/96A CH688353A5 (en) 1995-02-06 1996-02-06 Forms of paroxetine hydrochloride.
PT101827A PT101827B (en) 1995-02-06 1996-02-06 PAROXETINE CHLORIDRATE ANTIRETY SUBSTANTIALLY FREE OF PROPANE-2-OL CONNECTED, SEVERAL FORMS OF THE SAME, PROCESSES FOR PREPARATION, NEW USED INTERMEDIARIES FOR THEIR PREPARATION AND ITS USE.
CH01510/97A CH689229A5 (en) 1995-02-06 1996-02-06 Solvates of paroxetine hydrochloride.
CH02051/98A CH689804A5 (en) 1995-02-06 1996-02-06 Essentially propan-2-ol free paroxetine hydrochloride anhydrate
TR96/00096A TR199600096A2 (en) 1995-02-06 1996-02-06 New compounds.
US08/608,782 US5856493A (en) 1995-02-06 1996-02-29 Process for making novel form of paroxeting hydrochloride anhydrate
US08/733,874 US5872132A (en) 1995-02-06 1996-10-18 Form of paroxetine hydrochloride anhydrate
NO19970939A NO311519B1 (en) 1995-02-06 1997-02-28 Process for the preparation of paroxetine hydrochloride anhydrate
HK59397A HK59397A (en) 1995-02-06 1997-05-08 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
US08/922,060 US5900423A (en) 1995-02-06 1997-09-02 Form of paroxetine hydrochloride anhydrate
US08/922,067 US6133289A (en) 1995-02-06 1997-09-02 Paroxetine hydrochloride form A or C
US08/922,062 US6080759A (en) 1995-02-06 1997-09-02 Paroxetine hydrochloride form A
CY201598A CY2015A (en) 1995-02-06 1998-02-20 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
JP10342812A JPH11228571A (en) 1995-02-06 1998-12-02 New compound
CN001268872A CN1216055C (en) 1995-02-06 2000-08-31 New compound
DKPA200100223 DK200100223A (en) 1995-02-06 2001-02-12
DK200100774A DK200100774A (en) 1995-02-06 2001-05-16 New paroxetine hydrochloride anhydrate free of propan-2-ol - useful for treating medical disorders e.g. alcoholism, anxiety, depression, anorexia, obesity and pre-menstrual syndrome
NO20015070A NO20015070D0 (en) 1995-02-06 2001-10-18 Paroxetine hydrochloride anhydrate
US10/217,258 US20030004188A1 (en) 1995-02-06 2002-08-12 Novel compounds
ARP020103931A AR036856A2 (en) 1995-02-06 2002-10-18 ANOID PAROXETINE CHLORHYDRATE, AND PROCEDURE FOR PREPARATION
FI20030162A FI20030162A (en) 1995-02-06 2003-02-03 New compounds
FI20030370A FI20030370A (en) 1995-02-06 2003-03-12 New compounds
US10/786,192 US20040167227A1 (en) 1995-02-06 2004-02-25 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound

Publications (1)

Publication Number Publication Date
GB9502297D0 true GB9502297D0 (en) 1995-03-29

Family

ID=10769164

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9502297.6A Pending GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound

Country Status (4)

Country Link
AP (1) AP9600780A0 (en)
GB (1) GB9502297D0 (en)
LT (1) LT4100B (en)
ZA (1) ZA96875B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688827T2 (en) 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.

Also Published As

Publication number Publication date
LT96007A (en) 1996-10-25
ZA96875B (en) 1996-11-04
LT4100B (en) 1997-01-27
AP9600780A0 (en) 1997-08-05

Similar Documents

Publication Publication Date Title
GB9511935D0 (en) Novel compound
AP9701021A0 (en) Novel compounds
EP0802908A4 (en) Novel compounds
GB9507203D0 (en) Novel compounds
GB9509164D0 (en) Novel compounds
GB9518417D0 (en) Novel compound
GB9511933D0 (en) Novel compound
GB9511934D0 (en) Novel compound
GB9511936D0 (en) Novel compound
GB9503112D0 (en) Novel compound
GB9501157D0 (en) Novel compound
GB9500400D0 (en) Novel compound
GB9500399D0 (en) Novel compound
GB9511937D0 (en) Novel compound
GB9526538D0 (en) Novel compound
GB9502297D0 (en) Novel compound
GB9500447D0 (en) Compound
GB9503179D0 (en) Novel compounds
GB9509807D0 (en) Novel compounds
GB9502051D0 (en) Novel compounds
GB9502052D0 (en) Novel compounds
GB9503172D0 (en) Novel compounds
GB9503173D0 (en) Novel compounds
GB9503177D0 (en) Novel compounds
GB9500262D0 (en) Novel compounds